Induction of angiogenesis via topical delivery of basic-fibroblast growth factor from polyvinyl alcohol-dextran blend hydrogel in an ovine model of acute myocardial infarction

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 9, 2013, Pages 697-707

  Fathi, Ezzatollah ^b   Nassiri, Seyed Mahdi ^a   Atyabi, Nahid ^a   Ahmadi, Seyed Hossein ^c   Imani, Mohammad ^d   Farahzadi, Raheleh ^e   Rabbani, Shahram ^c   Akhlaghpour, Shahram ^f   Sahebjam, Mohammad ^c   Taheri, Mohammad ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b UNIVERSITY OF TABRIZ   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRAN POLYMER AND PETROCHEMICAL INSTITUTE   (Iran)

^e TARBIAT MODARES UNIVERSITY   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiogenesis; Animal model; BFGF; Biomaterials; Myocardial infarction; Ovine; Polyvinyl alcohol dextran hydrogel

Indexed keywords

ANIMALS; BIOCOMPATIBILITY; CARDIOLOGY; CELL CULTURE; DEXTRAN; ECHOCARDIOGRAPHY; FIBROBLASTS; HEART; MAGNETIC RESONANCE IMAGING; POLYVINYL ALCOHOLS; PROTEINS;

ANGIOGENESIS; ANIMAL MODEL; BASIC FIBROBLAST GROWTH FACTOR; BFGF; BLEND HYDROGELS; CARDIAC FUNCTIONS; MYOCARDIAL INFARCTION; OVINE; OVINE MODEL; POLYVINYL ALCOHOL-DEXTRAN HYDROGEL;

HYDROGELS;

DEXTRAN; FIBROBLAST GROWTH FACTOR 2; POLYVINYL ALCOHOL;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CARDIOVASCULAR MAGNETIC RESONANCE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG DELIVERY SYSTEM; ECHOCARDIOGRAPHY; ELECTRON MICROSCOPY; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE CELL; HISTOLOGY; HYDROGEL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEEP; SUSTAINED DRUG RELEASE; THORACOTOMY; WALL STRESS; WESTERN BLOTTING;

ANGIOGENESIS; ANIMAL MODEL; BFGF; BIOMATERIALS; MYOCARDIAL INFARCTION; OVINE; POLYVINYL ALCOHOL-DEXTRAN HYDROGEL;

ANIMALS; CORONARY VESSELS; DEXTRANS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; ECHOCARDIOGRAPHY; FIBROBLAST GROWTH FACTOR 2; HYDROGELS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MICROSCOPY, ELECTRON; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEOVASCULARIZATION, PATHOLOGIC; POLYVINYL ALCOHOL; SHEEP;

EID: 84882283394     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1460     Document Type: Article

References (40)

1. Amado LC, Saliaris AP, Schuleri KH et al. 2005; Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102: 11474-11479.
2. Atsma DE, Fibbe WE, Rabelink TJ. 2007; Opportunities and challenges for mesenchymal stem cell-mediated heart repair. Curr Opin Lipidol 18: 645-649.
3. Brette F, Orchard C. 2003; T-tubule function in mammalian cardiac myocytes. Circ Res 92: 1182-1192.
4. Cao L, Arany PR, Wang YS, Mooney DJ. 2009; Promoting angiogenesis via manipulation of VEGF responsiveness with notch signaling. Biomaterials 30: 4085-4093.
5. Carmeliet P. 2000; Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395.
6. Detillieux KA, Cattini PA, Kardami E. 2004; Beyond angiogenesis: the cardioprotective potential of fibroblast growth factor-2. Can J Physiol Pharmacol 82: 1044-1052.
7. Dogan AK, Gümüşderelioglu M, Aksöz E. 2005; Controlled release of EGF and bFGF from dextran hydrogels in vitro and in vivo. J Biomed Mater Res B Appl Biomater 74: 504-510.
8. Emerich DF, Silva E, Ali O et al. 2010; Injectable VEGF hydrogels produce near complete neurological and anatomical protection following cerebral ischemia in rats. Cell Transpl 19: 1063-1071.
9. Fathi E, Atyabi N, Imani M, Alinejad Z. 2011; Physically crosslinked polyvinyl alcohol-dextran blend xerogels: morphology and thermal behavior. Carbohydr Polym 84: 145-152.
10. Kamura S, Matsumoto Y, Fukushi JI et al. 2010; Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway. Br J Cancer 103: 370-381.
11. Kardami E, Detillieux K, Ma X et al. 2007; Fibroblast growth factor-2 and cardioprotection. Heart Fail Rev 12: 267-277.
12. Kawasuji M, Nagamine H, Ikeda M et al. 2000; Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor. Ann Thorac Surg 69: 1155-1161.
13. Kelly DJ, Rosen AB, Schuldt AJ et al. 2009; Increased myocyte content and mechanical function within a tissue-engineered myocardial patch following implantation. Tissue Eng Part A 15: 2189-2201.
14. Kim BO, Tian H, Prasongsukarn K et al. 2005; Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 112(9, suppl): I96-104.
15. Kim C, Li RK, Li G et al. 2007; Effects of cell-based angiogenic gene therapy at 6months: persistent angiogenesis and absence of oncogenicity. Ann Thorac Surg 83: 640-646.
16. Kong HJ, Kim ES, Huang YC, Mooney DJ. 2008; Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA. Pharm Res 25: 1230-1238.
17. Ladokhin AS. 2000; Fluorescence spectroscopy in peptide and protein analysis. In Encylopedia of Analytical Chemistry, Meyers RA (ed). Wiley: Chichester, UK; 5762-5779.
18. Laham RJ, Chronos N, Pike M et al. 2000; Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of phase I open-label dose escalation study. J Am Coll Cardiol 36: 2132-2139.
19. Landau C, Jacobs AK, Haudenschild CC. 1995; Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. Am Heart J 129: 924-931.
20. Lopez JJ, Edelman ER, Stamler A et al. 1997; Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia: a comparison of angiographic, echocardiographic and coronary flow parameters. J Pharmacol Exp Ther 282: 385-390.
21. Nassiri SM, Khaki Z, Soleimani M et al. 2007; The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction. J Biomed Sci 14: 745-755.
22. Nedeau AE, Bauer RJ, Gallagher K et al. 2008; A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells. Exp Cell Res 314: 2176-2186.
23. Nelson DM, Ma Z, Fujimoto KL et al. 2011; Intra-myocardial biomaterial injection therapy in the treatment of heart failure: materials, outcomes and challenges. Acta Biomater 7: 1-15.
24. Nerem RM. 2007; Cell-based therapies: from basic biology to replacement, repair, and regeneration. Biomaterials 28: 5074-5077.
25. Peppas NA. 1975; Turbidometric studies of aqueous poly(vinyl alcohol) solutions. Makromol Chem 176: 3433-3440.
26. Post MJ, Laham R, Sellke FW, Simons M. 2001; Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc Res 49: 522-531.
27. Rabbani S, Ahmadi H, Fayazzadeh E et al. 2008; Development of an ovine model of myocardial infarction. ANZ J Surg 78: 78-81.
28. Ratliff BB, Ghaly T, Brudnicki P et al. 2010; Endothelial progenitors encapsulated in bioartificial niches are insulated from systemic cytotoxicity and are angiogenesis competent. Am J Physiol Renal Physiol 299: F178-186.
29. Rodrigues M, Griffith LG, Wells A. 2010; Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther 1: 32.
30. Rosengart TK, Lee LY, Patel SR et al. 1999; Six-month assessment of a phase I trial of angiogenesis gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg 230: 466-470.
31. Santiago JJ, Ma X, McNaughton LJ et al. 2011; Preferential accumulation and export of high molecular weight FGF-2 by rat cardiac non-myocytes. Cardiovasc Res 89: 139-147.
32. Sellke FW, Laham RJ, Edelman ER et al. 1998; Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann Thorac Surg 65: 1540-1544.
33. Shao ZQ, Takaji K, Katayama Y et al. 2006; Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model. Circ J 70: 471-477.
34. Silva EA, Mooney DJ. 2007; Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost 5: 590-598.
35. Simons M, Bonow RO, Chronos NA et al. 2000; Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 102: E73-86.
36. Takehara N, Tsutsumi Y, Tateishi K et al. 2008; Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol 52: 1858-1865.
37. Thomopoulos S, Kim HM, Das R et al. 2010; The effects of exogenous basic fibroblast growth factor on intrasynovial flexor tendon healing in a canine model. J Bone Joint Surg Am 92: 2285-2293.
38. Vale PR, Losordo DW, Milliken CE et al. 2001; Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 103: 2138-2143.
39. Wall ST, Walker JC, Healy KE et al. 2006; Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 114: 2627-2635.
40. Wollert KC, Drexler H. 2010; Cell therapy for the treatment of coronary heart disease: a critical appraisal.Nat Rev Cardiol 7: 204-215.